Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:CSCI - Post by User

Post by prophetoffactzon Aug 31, 2024 10:37pm
551 Views
Post# 36204390

Juvente PGX-OBG/Avenanthramide: Wound healing & ageing skin

Juvente PGX-OBG/Avenanthramide: Wound healing & ageing skin
Based on the research findings, a cream containing PGX oat beta glucan impregnated with avenanthramide could potentially be very effective for wound healing and skin health:

Wound Healing Benefits

The combination of avenanthramides (AVN) and beta glucan (BG) showed promising results for accelerating wound closure and improving healing quality:
  • AVN reduced inflammation and scarring, leading to tissue that more closely resembled normal skin architecture.
  • BG increased angiogenesis (formation of new blood vessels) and improved collagen fiber structure.
A topical cream formulation could potentially deliver these benefits effectively, as beta glucan has been shown to penetrate to deeper skin layers.

Anti-Aging Potential

This formulation may also provide anti-aging benefits for skin:
  • Beta glucan acts as a natural moisture barrier and film-forming agent.
  • It smoothes wrinkles and reduces visible signs of aging.
  • Beta glucan relieves dry and itchy skin by replenishing the skin's moisture barrier.

Advantages of PGX Technology

Ceapro's PGX (Pressurized Gas eXpanded liquid) technology offers some key advantages:
  • It produces a highly purified liquid beta glucan.
  • The resulting product is non-GMO, allergen-free, and not tested on animals.
  • PGX allows for the potential impregnation or encapsulation of bioactive compounds like avenanthramides with beta glucan.

Potential Effectiveness

While the original study used injections, a topical cream using PGX technology could still be highly effective:
  1. Deep Penetration: Beta glucan can deliver compounds to the deepest levels of the skin, potentially mimicking some benefits of injection.
  2. Synergistic Effects: The combination of AVN and BG showed complementary benefits in the study, which could be preserved in a cream formulation.
  3. Ease of Use: A topical cream would be much more convenient for regular use compared to injections, potentially improving compliance and long-term benefits.
  4. Versatility: This formulation could address multiple skin concerns simultaneously, from wound healing to anti-aging.
While clinical studies would be needed to confirm the efficacy of a topical cream compared to injections, the existing research suggests that a PGX oat beta glucan cream impregnated with avenanthramide has significant potential for both wound healing and anti-aging applications.

<< Previous
Bullboard Posts
Next >>